CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

Health Secretary Robert F. Kennedy Jr. called the treatment 'a powerful glimpse into the future of personalized medicine' ...

The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...

In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...

What scientific knowledge is and is not presumed in legal reasoning, and what are the differences between what is and what is ...

According to Nova One Advisor, the global genomics data analysis market size is calculated at USD 7.91 billion in 2025 and is ...

According to MarketsandMarkets™, The agriculture biotechnology market is projected to grow from USD 92.19 billion in 2025 to ...

Intellia Therapeutics, Inc. is rated Hold due to uncertainty from dosing pause in its MAGNITUDE program for ATTR. Learn more ...

Professor David Williams, a New Zealander working on gene therapy at UCLA, has warned that the Bill is “unfair to farmers” and based on false assumptions about precision and safety. He points to ...

Cathy Tie, who launched her first biotech in SF's IndieBio, now leads Manhattan Genomics in controversial push to edit human ...

A new scalable technique enables the generation of human kidney organoids by integrating them into perfused pig kidneys.

Washington University researchers discovered how yellow fever and tick-borne encephalitis viruses enter human cells and ...